Critical Lung Ischemia Treatment
Get Free Consultation on Stem Cell Therapy for Critical Lung Ischemia Treatment
Stem Cell Treatment For Critical Limb Ischemia
Critical Limb Ischemia is the condition with chronic ischemic at-rest pain that may progressively lead to severe skin ulcers, gangrene, or limb loss. The condition is typically related to the objectively proven severe blockage in the artery. The disease implies, chronicity and is usually associated with multiple sites of arterial obstruction that severely reduced blood flow to the tissues. The disease is clinically manifested as rest pain, non healing wounds and/or tissue necrosis.
Ischemic pain can be associated with the burning sensation in the ball of the foot and toes, which can be worsened at night may be because of the loss of gravity assisted flow to the foot. In the past few years the most significant change in critical lung ischemia treatment has been the increasing tendency to shift from bypass surgery to less invasive stem cell therapy for critical lung ischemia as first-choice causing revascularization of the damaged tissue and removal of plaque deposits to a certain extent.
Major Manifestations of CLI, in patients include the following:
- Pain in the legs and feet when the person is at rest and not moving (also called “ischemic rest pain”)
- Sores or infections on the legs and feet that won’t heal
- Faint or absent pulse in the leg or foot below the blockage
Stem Cells Therapy for Critical Lung Ischemia Treatment: Advancells Protocol
Stem cell treatment at Advancells involves exploitation of the most potent stem cells isolated from patients own Bone marrow or Adipose tissue or may be both depending upon the assessment. Our top priority is to provide very comprehensive, individualized treatment pattern which is best suited for the patients undergoing stem cell treatment for critical lung ischemia. With extensive research these challenges are now comprehensible to therapeutic ventures resulting in new treatments of critical lung ischemia using autologous treatment/allogenic transplant for adipose-derived mesenchymal stromal cells treatment and bone marrow stromal cells treatment. This new insight on the treatment of critical lung ischemia has helped in identifying the potential to overcome critical lung ischemia with stem cells, primarily using autologous stem cell transplant in form of hematopoietic stem cell transplant or mesenchymal stromal cells treatment.
Stem Cell Treatment for Critical Lung Ischemia at Advancells is divided into 4 Steps
Processing of stem cells
CAUSES OF Critical limb ischemia
peripheral artery disease
high blood pressure
SYMPTOMS OF Critical limb ischemia
Pain or numbness in the feet
Thickening of the toenails
Absent pulse in the legs or feet
Open sores, skin infections or ulcers
Dry gangrene of the legs or feet
Why Choose Stem Cell Therapy?
Must Read Articles on Critical Limb Ischemia
Chronic Limb Ischemia is the most severe form of peripheral artery disease, characterized by blocked arteries and poor supply of oxygenated blood, to the extremities, such as arms and legs. Although initial symptoms are very subtle, through some of the general...
What is Critical Limb Ischemia? Limb ischemia refers to obstruction of the arteries leading to reduced flow of blood to the limbs (hand, arms and feet). It is categorized into Acute Limb Ischemia (ALI) or Critical Limb Ischemia (CLI) depending on the severity or...
Imagine waking up in the middle of the night from burning pain in legs. Even worse, it is aggravated at resting position and relieved only by sitting or standing. A dreadful dream isn’t it? This exactly describes the suffering of a patient with Critical Limb Ischemia...
Statistics of Overall Improvement of Critical Limb Ischemia through Stem Cell Therapy
Advancells is a strong advocate of greater transparency in medical procedures in general and Stem Cells Procedures in particular. As a part of our effort of bringing transparent procedures to our clients, we provide each client a Third Party Certificate (from an internationally accredited lab) for the cell count and viability of the cells that we are able to process from the autologous cell source of the patient. To view the sample copy of the certificate click here